Additional modalities for treating acute seizures in children: overview

Area of Science:

• Neurology
• Pharmacology

Background:

• Pharmacologic interventions for acute repetitive seizures and status epilepticus share similarities.
• Treatment selection depends on drug properties like onset, activity spectrum, administration, half-life, safety margin, and CNS redistribution.

Purpose of the Study:

• To outline optimal pharmacologic strategies for managing acute seizures and status epilepticus.
• To emphasize early intervention in patients at risk for prolonged or generalized seizures.

Main Methods:

• Review of current pharmacologic interventions for acute seizures and status epilepticus.
• Discussion of key drug characteristics influencing treatment choice.

Main Results:

• Benzodiazepines are established as first-line agents, with phenytoin/fosphenytoin and phenobarbital as subsequent options.
• Short-acting benzodiazepines can reduce emergency department visits when administered timely.
• Intravenous valproate presents a new option for breakthrough seizures in children on oral valproate.

Conclusions:

• Early initiation of appropriate pharmacologic treatment is vital for patients prone to seizure clusters or status epilepticus.
• A comprehensive understanding of drug properties guides effective seizure management.
• Recent advancements, such as intravenous valproate, expand therapeutic options for specific patient populations.